Laronidase Completed Phase 3 Trials for Mucopolysaccharidosis V / Type 1 Mucopolysaccharidosis / Hurler-Scheie Syndrome / Hurlers Syndrome Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00146770Phase 3 Extension Study of the Safety and Efficacy of Aldurazyme® (Laronidase) in Mucopolysaccharidosis I (MPS I) Patients
NCT00258011Study of Aldurazyme® Replacement Therapy in Patients With Mucopolysaccharidosis I (MPS I) Disease